FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to combination, composition and set designed for treatment of proliferative diseases, containing epothilones and antimetabolites chosen from 5-fluorouracil, tegafur, gemcitabine and capecitabine and, optionally antidiarrheal agent.
EFFECT: higher efficiency of treatment.
9 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS INCLUDING EPOTHILONES AND THEIR PHARMACEUTICAL APPLICATION | 2003 |
|
RU2379032C9 |
| COMBINATIONS CONTAINING ANTIDIARRHEAL AGENT AND EPOTHYLON OR EPOTHYLON DERIVATIVES | 2002 |
|
RU2330661C2 |
| USE OF 4-PYRIDYLMETHYLPHTHALAZINES IN CANCER TREATMENT | 2002 |
|
RU2320344C2 |
| METHOD OF TREATING CANCER USING A COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS | 2016 |
|
RU2768621C1 |
| COMPOSITIONS CONTAINING EPOTHILONES, AND APPLICATION THEREOF FOR CARCINOID SYNDROME TREATMENT | 2002 |
|
RU2341261C2 |
| COMBINATIONS INCLUDING EPOTHILONES, AND THEIR PHARMACEUTICAL APPLICATION | 2002 |
|
RU2375058C2 |
| BIOMARKERS | 2005 |
|
RU2429297C2 |
| BIOMARKER | 2005 |
|
RU2385944C2 |
| COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
| METHODS AND COMBINED THERAPEUTIC PRODUCT FOR THE TREATMENT OF BILE DUCTS CANCER | 2019 |
|
RU2793543C2 |
